Category icon
Home Screening for Stroke Prevention: A Practical Assessment

Jeroen J Bax, Gerhard Hindricks, Keitaro Senoo

Category icon
APSC Consensus on Optimising CV Outcomes in T2D

Jack Wei Chieh Tan, David Sim, Junya Ako, et al

Category icon
Renin–Angiotensin–Aldosterone System and COVID-19

Eliecer Coto, Pablo Avanzas, Juan Gómez,

Category icon
The Science of Ultrasound Renal Denervation

Philipp Lurz, Michael Joner, Felix Mahfoud et al

Category icon
Balloon Pulmonary Angioplasty: State of the Art

John G Coghlan, Alexander MK Rothman, Stephen P Hoole,

Category icon
The New Era in AF Screening at Home

Bernd Sanner, Keitaro Senoo, Faizel Osman

Category icon
Obstructive Sleep Apnoea Syndrome and Cardiovascular Risk

María Pilar Resano-Barrio, Ramón Arroyo-Espliguero, María Carmen Viana-Llamas, et al

About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Related Articles

Articles

Noise Pollution and Arterial Hypertension

Thomas Münzel, Mette Sørensen,

Citation: European Cardiology Review 2017;12(1):26–9

Practical Applications for Single Pill Combinations in the Cardiovascular…

Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz,

Citation: Cardiac Failure Review 2017;3(1):40–5.

Noise Pollution and Arterial Hypertension: Can we Remain Mute Anymore?

Sreenivasa Rao Kondapally Seshasai, Juan Carlos Kaski,

Citation: European Cardiology Review 2017;12(1):24–5.

Pharmacologic Strategies for Management of Pulmonary Arterial Hypertension

Rebecca L Attridge, Rebecca D Moote, Deborah J Levine,

Citation: US Cardiology Review 2016;10(2):78–84